Volume 68, Issue 5, Pages (November 2015)

Slides:

Advertisements

Similar presentations

Volume 72, Issue 1, Pages (July 2017)

Advertisements

Volume 70, Issue 3, Pages (September 2016)

The PSA Era is not Over for Prostate Cancer

Volume 59, Issue 2, Pages (February 2011)

Volume 68, Issue 2, Pages (August 2015)

Volume 51, Issue 2, Pages (February 2007)

Volume 62, Issue 5, Pages (November 2012)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Prostate cancer mortality as a factor of Gleason score and age at diagnosis in men managed conservatively. (Adapted, with permission, from Albertsen PC.

Testosterone Therapy in Men With Prostate Cancer

Global Trends in Testicular Cancer Incidence and Mortality

Volume 60, Issue 5, Pages (November 2011)

Volume 60, Issue 5, Pages (November 2011)

Volume 73, Issue 6, Pages (June 2018)

Volume 53, Issue 5, Pages (May 2008)

Volume 64, Issue 4, Pages (October 2013)

Volume 51, Issue 4, Pages (April 2007)

Volume 70, Issue 4, Pages (October 2016)

Volume 71, Issue 5, Pages (May 2017)

Prostate Cancer Epidemic in Sight?

Volume 62, Issue 6, Pages (December 2012)

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Prostate Cancer Detection: A View of the Future

Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance Adam B. Weiner, Ruth Etzioni, Scott E. Eggener

Volume 54, Issue 5, Pages (November 2008)

Volume 68, Issue 3, Pages (September 2015)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 69, Issue 3, Pages (March 2016)

Volume 57, Issue 4, Pages e41-e42 (April 2010)

Volume 73, Issue 4, Pages (April 2018)

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Yuanshan Cui, Yong Zhang European Urology

Global Burden of Urologic Cancers, 1990–2013

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 68, Issue 6, Pages (December 2015)

Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old P. Perrin,

Volume 63, Issue 3, Pages (March 2013)

Volume 62, Issue 4, Pages (October 2012)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Tillmann Loch, Pat Fox Fulgham European Urology

Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study Stephen H. Culp, Paul.

Physical Activity and Survival After Prostate Cancer

Volume 62, Issue 6, Pages (December 2012)

Volume 50, Issue 5, Pages (November 2006)

Volume 58, Issue 3, Pages (September 2010)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

Volume 72, Issue 4, Pages (October 2017)

Volume 71, Issue 5, Pages (May 2017)

Testicular Cancer Variations in Time and Space in Europe

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Volume 59, Issue 4, Pages (April 2011)

Volume 72, Issue 1, Pages (July 2017)

European Urology is “Your” Journal

Thomas Steuber, Matthew Frank O'Brien, Hans Lilja European Urology

Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.

Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.

Statin use and clinical outcomes among pneumonia patients

Volume 68, Issue 2, Pages (August 2015)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Volume 51, Issue 2, Pages (February 2007)

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Quality of life: An outcomes perspective

Does PSA Testing Influence the Natural History of Prostate Cancer?

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 68, Issue 5, Pages 805-811 (November 2015) Fifteen-year Outcomes Following Conservative Management Among Men Aged 65 Years or Older with Localized Prostate Cancer Grace L. Lu-Yao, Peter C. Albertsen, Dirk F. Moore, Yong Lin, Robert S. DiPaola, Siu-Long Yao European Urology Volume 68, Issue 5, Pages 805-811 (November 2015) DOI: 10.1016/j.eururo.2015.03.021 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 Competing risks of death by age at diagnosis, cancer stage, and grade. Dark shading indicates prostate cancer–specific mortality and light shading mortality due to competing causes; nonshaded areas represent the probability of being alive. Results for well-differentiated disease are not shown because estimates were unstable due to limited sample sizes. European Urology 2015 68, 805-811DOI: (10.1016/j.eururo.2015.03.021) Copyright © 2015 European Association of Urology Terms and Conditions